Post Marketing Surveillance on Long Term Drug Use of Trazenta Tablets in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Linagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 26 Oct 2017 Status changed from active, no longer recruiting to completed.
- 14 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
- 14 Feb 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2017.